What CleanNA does

CleanNA is a Netherlands-based, privately held life sciences company founded in 2018 and headquartered in Waddinxveen. According to its firmographic profile, the company focuses on supplying high quality products and magnetic bead-based kits for both DNA and RNA analysis to an evolving market — positioning it in the nucleic acid extraction and purification reagents segment that serves molecular biology research, diagnostic development, and biotechnology workflows. The company operates with a headcount of 11-50 employees and distributes through channels that are not publicly disclosed; its website (cleanna.com) currently presents only a verification/loading page and does not expose product catalogs, pricing, or customer references.

The core technology revolves around magnetic bead-based isolation chemistry, a mature but technically demanding approach in which functionalized beads selectively bind nucleic acids under controlled buffer conditions for downstream applications such as PCR, sequencing, and genotyping. CleanNA's differentiation, pricing model, customer segmentation, and revenue mechanics are not disclosed in the available sources. A 2025-09-23 capital/strategic event listed INTEGRA as both investor and lead investor with a reported $0 amount, which most likely represents a non-equity strategic alignment or partnership registration rather than a traditional priced funding round, though full terms are not available.

Based on the available evidence, CleanNA should be characterized as a small, privately held, specialist reagent vendor in the European molecular biology tools market. The combination of limited public commercial footprint, the absence of disclosed financials or customer references, and the minimal website substance constrains any deeper analytical conclusions about commercial traction, competitive positioning, or scale. Diligence should prioritize obtaining product portfolio detail, customer logos and concentration, geographic mix, distributor agreements, and any formal terms of the INTEGRA relationship before assigning a defensible valuation or growth thesis.

Name

CleanNA

Website

https://cleanna.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

CleanNA is a Netherlands-based, privately held life sciences supplier founded in 2018 that provides magnetic bead-based kits for DNA and RNA analysis to research, diagnostic, and biotechnology customers across an evolving nucleic acid extraction market.

Ownership category

akta.pro rank

Product category

Molecular Biology Reagents

NAICS

Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• Magnetic bead kits
• DNA purification
• RNA extraction
• Nucleic acid isolation
• Molecular biology reagents

Headquarters

HQ city

Waddinxveen

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Core offering

CleanNA focuses on supplying an evolving market with high quality products and magnetic bead-based kits for both DNA and RNA analysis. The company manufactures reagent kits used by laboratories and researchers for nucleic acid isolation and purification workflows in molecular biology applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Magnetic bead-based DNA analysis kits
• Magnetic bead-based RNA analysis kits

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• QIAGEN: Global leader in nucleic acid extraction/sample preparation technologies with magnetic bead-based kits (e.g., MagAttract). Directly competes with CleanNA in DNA/RNA purification consumables used across research and diagnostics workflows.
• Promega: US-headquartered life sciences reagents provider with Maxwell and related nucleic acid extraction systems. Competes in the same downstream workflow for DNA/RNA purification kits and reagents.
• Macherey-Nagel: German specialist in nucleic acid purification with the NucleoMag bead-based kits for DNA/RNA extraction. Closely comparable as a mid-sized European consumables specialist with overlapping chemistry and OEM/private-label relationships.

Emerging players

• LGC Biosearch Technologies: Provides genomics reagents and kits including custom nucleic acid extraction solutions. Adjacent specialist serving molecular biology and diagnostics customers similar to CleanNA.
• AutoGen (formerly AlphaHelix): Specializes in automated nucleic acid extraction instruments and reagent kits, including bead-based chemistries. Comparable as a smaller specialist whose focus overlaps directly with CleanNA's workflow niche.
• Analytik Jena: Mid-sized German life sciences tools company offering the InnuPure extraction platform and related kits. Comparable as a smaller European specialist with overlapping DNA/RNA extraction solutions.

Broad incumbents

• Roche Diagnostics: Major diagnostics incumbent offering the MagNA Pure automated extraction systems and reagents. Overlaps CleanNA in the clinical/diagnostic nucleic acid extraction kit market, though as part of a much broader diagnostics portfolio.
• Thermo Fisher Scientific: Broad life sciences tools incumbent offering the MagMAX magnetic bead kits and KingFisher automated extraction platforms. Directly overlaps CleanNA's bead-based kit offering, though within a much larger portfolio spanning instruments, reagents and services.
• Beckman Coulter Life Sciences (Danaher): Provides SPRI/Ampure bead-based chemistries and automated nucleic acid extraction workflows. Comparable as an incumbent reagent/automation supplier whose bead technology addresses the same application as CleanNA's kits.
• PerkinElmer / Revvity: Provides chemagic automated extraction instruments and associated bead-based kits for DNA/RNA. An incumbent reagent/automation vendor serving clinical and research labs in the same workflow as CleanNA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CleanNA